Selected research
Industry Research
Chronic Disease Data Management Software Industry Research Report 2026
Market perspective
The global Chronic Disease Data Management Software market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Chronic Disease Data Management Software market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Chronic Disease Data Management Software market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Chronic Disease Data Management Software market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Chronic Disease Data Management Software include Vistel, Tianjin Jiuan Medical Electronics, Human Metabolomics Institute, Inc., ScienceSoft, Qure4u, Cognizant, Infosys Limited, Pegasystems Inc. and Siemens Healthcare Private Limited, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Chronic Disease Data Management Software market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Chronic Disease Data Management Software.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Chronic Disease Data Management Software Market by Company
Vistel
Tianjin Jiuan Medical Electronics
Human Metabolomics Institute, Inc.
ScienceSoft
Qure4u
Cognizant
Infosys Limited
Pegasystems Inc.
Siemens Healthcare Private Limited
MINES & Associates Inc
Allscripts
HealthSmart
Philips
EXL Healthcare
EquityNet
Cabot Solutions Inc.
VITECH
Empeek
Arkenea
Chronic Disease Data Management Software Segment by Type
Cloud-based
Local Deployment
Chronic Disease Data Management Software Segment by Application
Arthropathy
Cardiovascular Diseases
Cancer
Diabetic
Others
Chronic Disease Data Management Software Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chronic Disease Data Management Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Chronic Disease Data Management Software and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chronic Disease Data Management Software.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Chronic Disease Data Management Software companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Cloud-based
- Local Deployment
Applications
- Arthropathy
- Cardiovascular Diseases
- Cancer
- Diabetic
- Others
Companies covered
- Vistel
- Tianjin Jiuan Medical Electronics
- Human Metabolomics Institute, Inc.
- ScienceSoft
- Qure4u
- Cognizant
- Infosys Limited
- Pegasystems Inc.
- Siemens Healthcare Private Limited
- MINES & Associates Inc
- Allscripts
- HealthSmart
- Philips
- EXL Healthcare
- EquityNet
- Cabot Solutions Inc.
- VITECH
- Empeek
- Arkenea
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Chronic Disease Data Management Software by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Cloud-based
- 2.2.3 Local Deployment
- 2.3 Chronic Disease Data Management Software by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Arthropathy
- 2.3.3 Cardiovascular Diseases
- 2.3.4 Cancer
- 2.3.5 Diabetic
- 2.3.6 Others
- 2.4 Assumptions and Limitations
3 Chronic Disease Data Management Software Breakdown Data by Type
- 3.1 Global Chronic Disease Data Management Software Historic Market Size by Type (2021-2026)
- 3.2 Global Chronic Disease Data Management Software Forecasted Market Size by Type (2027-2032)
4 Chronic Disease Data Management Software Breakdown Data by Application
- 4.1 Global Chronic Disease Data Management Software Historic Market Size by Application (2021-2026)
- 4.2 Global Chronic Disease Data Management Software Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Chronic Disease Data Management Software Market Perspective (2021-2032)
- 5.2 Global Chronic Disease Data Management Software Growth Trends by Region
- 5.2.1 Global Chronic Disease Data Management Software Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Chronic Disease Data Management Software Historic Market Size by Region (2021-2026)
- 5.2.3 Chronic Disease Data Management Software Forecasted Market Size by Region (2027-2032)
- 5.3 Chronic Disease Data Management Software Market Dynamics
- 5.3.1 Chronic Disease Data Management Software Industry Trends
- 5.3.2 Chronic Disease Data Management Software Market Drivers
- 5.3.3 Chronic Disease Data Management Software Market Challenges
- 5.3.4 Chronic Disease Data Management Software Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Chronic Disease Data Management Software Players by Revenue
- 6.1.1 Global Top Chronic Disease Data Management Software Players by Revenue (2021-2026)
- 6.1.2 Global Chronic Disease Data Management Software Revenue Market Share by Players (2021-2026)
- 6.2 Global Chronic Disease Data Management Software Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Chronic Disease Data Management Software Head Office and Area Served
- 6.4 Global Chronic Disease Data Management Software Players, Product Type & Application
- 6.5 Global Chronic Disease Data Management Software Manufacturers Established Date
- 6.6 Global Chronic Disease Data Management Software Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Chronic Disease Data Management Software Market Size (2021-2032)
- 7.2 North America Chronic Disease Data Management Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Chronic Disease Data Management Software Market Size by Country (2021-2026)
- 7.4 North America Chronic Disease Data Management Software Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Chronic Disease Data Management Software Market Size (2021-2032)
- 8.2 Europe Chronic Disease Data Management Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Chronic Disease Data Management Software Market Size by Country (2021-2026)
- 8.4 Europe Chronic Disease Data Management Software Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Chronic Disease Data Management Software Market Size (2021-2032)
- 9.2 Asia-Pacific Chronic Disease Data Management Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Chronic Disease Data Management Software Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Chronic Disease Data Management Software Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Chronic Disease Data Management Software Market Size (2021-2032)
- 10.2 South America Chronic Disease Data Management Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Chronic Disease Data Management Software Market Size by Country (2021-2026)
- 10.4 South America Chronic Disease Data Management Software Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Chronic Disease Data Management Software Market Size (2021-2032)
- 11.2 Middle East & Africa Chronic Disease Data Management Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Chronic Disease Data Management Software Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Chronic Disease Data Management Software Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Vistel
- 12.1.1 Vistel Company Information
- 12.1.2 Vistel Business Overview
- 12.1.3 Vistel Revenue in Chronic Disease Data Management Software Business (2021-2026)
- 12.1.4 Vistel Chronic Disease Data Management Software Product Portfolio
- 12.1.5 Vistel Recent Developments
- 12.2 Tianjin Jiuan Medical Electronics
- 12.2.1 Tianjin Jiuan Medical Electronics Company Information
- 12.2.2 Tianjin Jiuan Medical Electronics Business Overview
- 12.2.3 Tianjin Jiuan Medical Electronics Revenue in Chronic Disease Data Management Software Business (2021-2026)
- 12.2.4 Tianjin Jiuan Medical Electronics Chronic Disease Data Management Software Product Portfolio
- 12.2.5 Tianjin Jiuan Medical Electronics Recent Developments
- 12.3 Human Metabolomics Institute, Inc.
- 12.3.1 Human Metabolomics Institute, Inc. Company Information
- 12.3.2 Human Metabolomics Institute, Inc. Business Overview
- 12.3.3 Human Metabolomics Institute, Inc. Revenue in Chronic Disease Data Management Software Business (2021-2026)
- 12.3.4 Human Metabolomics Institute, Inc. Chronic Disease Data Management Software Product Portfolio
- 12.3.5 Human Metabolomics Institute, Inc. Recent Developments
- 12.4 ScienceSoft
- 12.4.1 ScienceSoft Company Information
- 12.4.2 ScienceSoft Business Overview
- 12.4.3 ScienceSoft Revenue in Chronic Disease Data Management Software Business (2021-2026)
- 12.4.4 ScienceSoft Chronic Disease Data Management Software Product Portfolio
- 12.4.5 ScienceSoft Recent Developments
- 12.5 Qure4u
- 12.5.1 Qure4u Company Information
- 12.5.2 Qure4u Business Overview
- 12.5.3 Qure4u Revenue in Chronic Disease Data Management Software Business (2021-2026)
- 12.5.4 Qure4u Chronic Disease Data Management Software Product Portfolio
- 12.5.5 Qure4u Recent Developments
- 12.6 Cognizant
- 12.6.1 Cognizant Company Information
- 12.6.2 Cognizant Business Overview
- 12.6.3 Cognizant Revenue in Chronic Disease Data Management Software Business (2021-2026)
- 12.6.4 Cognizant Chronic Disease Data Management Software Product Portfolio
- 12.6.5 Cognizant Recent Developments
- 12.7 Infosys Limited
- 12.7.1 Infosys Limited Company Information
- 12.7.2 Infosys Limited Business Overview
- 12.7.3 Infosys Limited Revenue in Chronic Disease Data Management Software Business (2021-2026)
- 12.7.4 Infosys Limited Chronic Disease Data Management Software Product Portfolio
- 12.7.5 Infosys Limited Recent Developments
- 12.8 Pegasystems Inc.
- 12.8.1 Pegasystems Inc. Company Information
- 12.8.2 Pegasystems Inc. Business Overview
- 12.8.3 Pegasystems Inc. Revenue in Chronic Disease Data Management Software Business (2021-2026)
- 12.8.4 Pegasystems Inc. Chronic Disease Data Management Software Product Portfolio
- 12.8.5 Pegasystems Inc. Recent Developments
- 12.9 Siemens Healthcare Private Limited
- 12.9.1 Siemens Healthcare Private Limited Company Information
- 12.9.2 Siemens Healthcare Private Limited Business Overview
- 12.9.3 Siemens Healthcare Private Limited Revenue in Chronic Disease Data Management Software Business (2021-2026)
- 12.9.4 Siemens Healthcare Private Limited Chronic Disease Data Management Software Product Portfolio
- 12.9.5 Siemens Healthcare Private Limited Recent Developments
- 12.10 MINES & Associates Inc
- 12.10.1 MINES & Associates Inc Company Information
- 12.10.2 MINES & Associates Inc Business Overview
- 12.10.3 MINES & Associates Inc Revenue in Chronic Disease Data Management Software Business (2021-2026)
- 12.10.4 MINES & Associates Inc Chronic Disease Data Management Software Product Portfolio
- 12.10.5 MINES & Associates Inc Recent Developments
- 12.11 Allscripts
- 12.11.1 Allscripts Company Information
- 12.11.2 Allscripts Business Overview
- 12.11.3 Allscripts Revenue in Chronic Disease Data Management Software Business (2021-2026)
- 12.11.4 Allscripts Chronic Disease Data Management Software Product Portfolio
- 12.11.5 Allscripts Recent Developments
- 12.12 HealthSmart
- 12.12.1 HealthSmart Company Information
- 12.12.2 HealthSmart Business Overview
- 12.12.3 HealthSmart Revenue in Chronic Disease Data Management Software Business (2021-2026)
- 12.12.4 HealthSmart Chronic Disease Data Management Software Product Portfolio
- 12.12.5 HealthSmart Recent Developments
- 12.13 Philips
- 12.13.1 Philips Company Information
- 12.13.2 Philips Business Overview
- 12.13.3 Philips Revenue in Chronic Disease Data Management Software Business (2021-2026)
- 12.13.4 Philips Chronic Disease Data Management Software Product Portfolio
- 12.13.5 Philips Recent Developments
- 12.14 EXL Healthcare
- 12.14.1 EXL Healthcare Company Information
- 12.14.2 EXL Healthcare Business Overview
- 12.14.3 EXL Healthcare Revenue in Chronic Disease Data Management Software Business (2021-2026)
- 12.14.4 EXL Healthcare Chronic Disease Data Management Software Product Portfolio
- 12.14.5 EXL Healthcare Recent Developments
- 12.15 EquityNet
- 12.15.1 EquityNet Company Information
- 12.15.2 EquityNet Business Overview
- 12.15.3 EquityNet Revenue in Chronic Disease Data Management Software Business (2021-2026)
- 12.15.4 EquityNet Chronic Disease Data Management Software Product Portfolio
- 12.15.5 EquityNet Recent Developments
- 12.16 Cabot Solutions Inc.
- 12.16.1 Cabot Solutions Inc. Company Information
- 12.16.2 Cabot Solutions Inc. Business Overview
- 12.16.3 Cabot Solutions Inc. Revenue in Chronic Disease Data Management Software Business (2021-2026)
- 12.16.4 Cabot Solutions Inc. Chronic Disease Data Management Software Product Portfolio
- 12.16.5 Cabot Solutions Inc. Recent Developments
- 12.17 VITECH
- 12.17.1 VITECH Company Information
- 12.17.2 VITECH Business Overview
- 12.17.3 VITECH Revenue in Chronic Disease Data Management Software Business (2021-2026)
- 12.17.4 VITECH Chronic Disease Data Management Software Product Portfolio
- 12.17.5 VITECH Recent Developments
- 12.18 Empeek
- 12.18.1 Empeek Company Information
- 12.18.2 Empeek Business Overview
- 12.18.3 Empeek Revenue in Chronic Disease Data Management Software Business (2021-2026)
- 12.18.4 Empeek Chronic Disease Data Management Software Product Portfolio
- 12.18.5 Empeek Recent Developments
- 12.19 Arkenea
- 12.19.1 Arkenea Company Information
- 12.19.2 Arkenea Business Overview
- 12.19.3 Arkenea Revenue in Chronic Disease Data Management Software Business (2021-2026)
- 12.19.4 Arkenea Chronic Disease Data Management Software Product Portfolio
- 12.19.5 Arkenea Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst